NCT02994043

Brief Summary

The goal of the AIM Study is to examine the effectiveness of Mindfulness Based Relapse Prevention (MBRP) versus Relapse Prevention (RP) for the treatment of Alcohol Use Disorders (AUD) by implementing an 8-week long intervention and examining neurobiological, immunological, and epigenetic characteristics of AUD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
182

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 9, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 12, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 15, 2016

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2021

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

January 19, 2023

Completed
Last Updated

January 19, 2023

Status Verified

December 1, 2022

Enrollment Period

4.3 years

First QC Date

December 12, 2016

Results QC Date

July 19, 2022

Last Update Submit

December 22, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Heavy Drinking Days at Baseline

    Timeline Follow-back (TLFB) measure of heavy drinking days in the last month (4+ for women, 5+ for men)

    Baseline

  • Heavy Drinking Days at Week 4

    Timeline Follow-back (TLFB) measure of heavy drinking days in the last month (4+ for women, 5+ for men)

    Week 4

  • Heavy Drinking Days at Week 8

    Timeline Follow-back (TLFB) measure of heavy drinking days in the last month (4+ for women, 5+ for men)

    Week 8

  • Heavy Drinking Days at Week 20

    Timeline Follow-back (TLFB) measure of heavy drinking days in the last month (4+ for women, 5+ for men)

    Week 20

  • Heavy Drinking Days at Week 32

    Timeline Follow-back (TLFB) measure of heavy drinking days in the last month (4+ for women, 5+ for men)

    Week 32

Study Arms (2)

MBRP

ACTIVE COMPARATOR
Behavioral: Mindfulness-Based Relapse Prevention Therapy

RP

ACTIVE COMPARATOR
Behavioral: Relapse Prevention Therapy

Interventions

An 8-week, outpatient psychotherapy that combines mindfulness components with relapse prevention.

MBRP

An 8-week, outpatient psychotherapy that uses cognitive-behavioral components to reduce alcohol-related consequences.

RP

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Have a primary Diagnostic Statistical Manual-V (DSM-V) diagnosis of alcohol use disorder;
  • Must be within 10 days of last drink;
  • Must have been drinking heavily (criteria dependent upon individual?s age, gender, and BMI) for a consistent period of time;
  • Must have a breath alcohol level of 0 at screening;
  • Must have a Clinical Institute Withdrawal Assessment (CIWA) score less than 8 (indicating no need for medical detox);
  • Must have expressed a desire during their initial screen to reduce the number of drinks they regularly consume

You may not qualify if:

  • Currently taking any medications for the treatment of psychiatric disorders, including substance use disorders, mood disorders, and psychosis;
  • Pregnant, as indicated by a pregnancy test which will be administered at baseline;
  • Positive for, sedatives, opiates, cocaine, or amphetamine on drug screen at baseline;
  • Meets criteria for psychotic disorder, bipolar disorder, or a major depressive episode

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Denver

Denver, Colorado, 80045, United States

Location

Related Publications (3)

  • Skrzynski CJ, Karoly H, Ellingson JM, Hagerty SL, Bryan AD, Hutchison KE. Comparing the Efficacy of Mindfulness-Based Relapse Prevention Versus Relapse Prevention for Alcohol Use Disorder: A Randomized Control Trial. J Stud Alcohol Drugs. 2023 Jul;84(4):560-569. doi: 10.15288/jsad.21-00392. Epub 2023 Feb 1.

  • Karoly HC, Skrzynski CJ, Moe EN, Bryan AD, Hutchison KE. Exploring relationships between alcohol consumption, inflammation, and brain structure in a heavy drinking sample. Alcohol Clin Exp Res. 2021 Nov;45(11):2256-2270. doi: 10.1111/acer.14712. Epub 2021 Sep 22.

  • Karoly HC, Ross JM, Prince MA, Zabelski AE, Hutchison KE. Effects of cannabis use on alcohol consumption in a sample of treatment-engaged heavy drinkers in Colorado. Addiction. 2021 Sep;116(9):2529-2537. doi: 10.1111/add.15407. Epub 2021 Jan 26.

MeSH Terms

Conditions

Alcoholism

Interventions

Secondary Prevention

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

TherapeuticsPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPublic Health PracticePublic HealthEnvironment and Public Health

Results Point of Contact

Title
Jamie Laurin
Organization
University of Colorado Denver

Study Officials

  • Ken Hutchison

    University of Colorado Denver | Anschutz

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2016

First Posted

December 15, 2016

Study Start

November 9, 2016

Primary Completion

February 17, 2021

Study Completion

February 17, 2021

Last Updated

January 19, 2023

Results First Posted

January 19, 2023

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations